
AHR Stock Forecast & Price Target
AHR Analyst Ratings
Bulls say
American Healthcare REIT is poised for strong growth in the coming years, with revised earnings estimates and a significant increase in its net operating income expected through 2026 and 2027. The company's diversified portfolio, particularly its integrated senior health campuses and outpatient medical segments, offers potential for above-average organic growth. With low leverage and a strong balance sheet, American Healthcare REIT is well-positioned to navigate any potential challenges in the healthcare regulatory environment and continue its investment pipeline. While there are some risks, such as potential changes in the healthcare operating environment, the company's strong relationship with operator Trilogy Health Services and its successful track record past track record suggest the potential for continued success.
Bears say
American Healthcare REIT is facing potential headwinds in the future, as its recent $712 million forward equity adds up to over one billion dollars when combined with previous equity issuance and debt assumed through future acquisitions. This aggressive deployment of capital may lead to increased leverage and a potential drag on earnings growth. In addition, the company's focus on medical office buildings and skilled nursing facilities may face challenges in an increasingly competitive market, potentially hindering its ability to generate strong returns for investors.
This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.
AHR Analyst Forecast & Price Prediction
Start investing in AHR
Order type
Buy in
Order amount
Est. shares
0 shares